640 related articles for article (PubMed ID: 25609146)
1. Evaluation of a method for induction of praziquantel resistance in Schistosoma mansoni.
Lotfy WM; Hishmat MG; El Nashar AS; Abu El Einin HM
Pharm Biol; 2015 Aug; 53(8):1214-9. PubMed ID: 25609146
[TBL] [Abstract][Full Text] [Related]
2. Schistosoma mansoni: a method for inducing resistance to praziquantel using infected Biomphalaria glabrata snails.
Couto FF; Coelho PM; Araújo N; Kusel JR; Katz N; Jannotti-Passos LK; Mattos AC
Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):153-7. PubMed ID: 21537673
[TBL] [Abstract][Full Text] [Related]
3. Laboratory induced resistance to praziquantel in experimental schistosomiasis.
Ismail MM; Taha SA; Farghaly AM; el-Azony AS
J Egypt Soc Parasitol; 1994 Dec; 24(3):685-95. PubMed ID: 7844435
[TBL] [Abstract][Full Text] [Related]
4. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure.
Sabra AN; Botros SS
J Parasitol; 2008 Apr; 94(2):537-41. PubMed ID: 18564758
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoni.
Liang YS; Wang W; Dai JR; Li HJ; Tao YH; Zhang JF; Li W; Zhu YC; Coles GC; Doenhoff MJ
J Helminthol; 2010 Jun; 84(2):202-7. PubMed ID: 19765323
[TBL] [Abstract][Full Text] [Related]
6. Liposomal-praziquantel: efficacy against Schistosoma mansoni in a preclinical assay.
Frezza TF; Gremião MP; Zanotti-Magalhães EM; Magalhães LA; de Souza AL; Allegretti SM
Acta Trop; 2013 Oct; 128(1):70-5. PubMed ID: 23811113
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni.
Mattos AC; Pereira GC; Jannotti-Passos LK; Kusel JR; Coelho PM
Acta Trop; 2007 May; 102(2):84-91. PubMed ID: 17498638
[TBL] [Abstract][Full Text] [Related]
8. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
Fallon PG; Doenhoff MJ
Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
[TBL] [Abstract][Full Text] [Related]
10. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of two praziquantel treatments among primary school children in an area of high Schistosoma mansoni endemicity, Nile Delta, Egypt.
Barakat R; El Morshedy H
Parasitology; 2011 Apr; 138(4):440-6. PubMed ID: 21078223
[TBL] [Abstract][Full Text] [Related]
12. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.
Ismail M; Metwally A; Farghaly A; Bruce J; Tao LF; Bennett JL
Am J Trop Med Hyg; 1996 Aug; 55(2):214-8. PubMed ID: 8780463
[TBL] [Abstract][Full Text] [Related]
13. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
[TBL] [Abstract][Full Text] [Related]
14. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni: In vivo evaluation of Phyllanthus amarus hexanic and ethanolic extracts.
de Oliveira CNF; Frezza TF; Garcia VL; Figueira GM; Mendes TMF; Allegretti SM
Exp Parasitol; 2017 Dec; 183():56-63. PubMed ID: 29074138
[TBL] [Abstract][Full Text] [Related]
16. Resistance to praziquantel, effect of drug pressure and stability test.
Ismail MM; Farghaly AM; Dyab AK; Afify HA; el-Shafei MA
J Egypt Soc Parasitol; 2002 Aug; 32(2):589-600. PubMed ID: 12214936
[TBL] [Abstract][Full Text] [Related]
17. Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni.
Fallon PG; Sturrock RF; Niang AC; Doenhoff MJ
Am J Trop Med Hyg; 1995 Jul; 53(1):61-2. PubMed ID: 7625534
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of hyperbaric oxygen for experimental treatment of schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: assay in adult worms and oviposition.
Frezza TF; de Souza AL; Prado CC; de Oliveira CN; Gremião MP; Giorgio S; Dolder MA; Joazeiro PP; Allegretti SM
Acta Trop; 2015 Oct; 150():182-9. PubMed ID: 26215128
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility of a Brazilian wild rodent isolate of Schistosoma mansoni to praziquantel in mice.
Costa-Silva M; Barros Lde A; Garcia JS; Neves RH; Rodrigues-Silva R; Machado-Silva JR; Maldonado-Júnior A
Exp Parasitol; 2012 Apr; 130(4):394-9. PubMed ID: 22343042
[TBL] [Abstract][Full Text] [Related]
20. Biological and proteomic studies of Schistosoma mansoni with decreased sensitivity to praziquantel.
Abou-El-Naga IF; Amer EI; Boulos LM; El-Faham MH; Abou Seada NM; Younis SS
Comp Immunol Microbiol Infect Dis; 2019 Oct; 66():101341. PubMed ID: 31437686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
